Paos Holdings Berhad Valuation
Is PAOS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PAOS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PAOS (MYR0.4) is trading above our estimate of fair value (MYR0.22)
Significantly Below Fair Value: PAOS is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PAOS?
Other financial metrics that can be useful for relative valuation.
What is PAOS's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | RM71.56m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.08x |
Enterprise Value/EBITDA | 15.7x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does PAOS's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 32.7x | ||
NTPM NTPM Holdings Berhad | 70.6x | 80.5% | RM443.6m |
NOVA Nova Wellness Group Berhad | 14x | 18.4% | RM168.9m |
SUNZEN Sunzen Biotech Berhad | 34.1x | n/a | RM232.7m |
524136 Pee Cee Cosma Sope | 12.2x | n/a | ₹1.1b |
PAOS Paos Holdings Berhad | 80.8x | n/a | RM71.6m |
Price-To-Earnings vs Peers: PAOS is expensive based on its Price-To-Earnings Ratio (80.8x) compared to the peer average (32.7x).
Price to Earnings Ratio vs Industry
How does PAOS's PE Ratio compare vs other companies in the Asian Household Products Industry?
Price-To-Earnings vs Industry: PAOS is expensive based on its Price-To-Earnings Ratio (80.8x) compared to the Asian Household Products industry average (18.1x).
Price to Earnings Ratio vs Fair Ratio
What is PAOS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 80.8x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PAOS's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.